462 related articles for article (PubMed ID: 32342184)
1. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
[TBL] [Abstract][Full Text] [Related]
2. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
[TBL] [Abstract][Full Text] [Related]
3. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.
Schulze-Koops H; Specker C; Iking-Konert C; Holle J; Moosig F; Krueger K
Ann Rheum Dis; 2020 Jun; 79(6):840-842. PubMed ID: 32345619
[No Abstract] [Full Text] [Related]
4. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.
Wallace ZS; Bhana S; Hausmann JS; Robinson PC; Sufka P; Sirotich E; Yazdany J; Grainger R
Rheumatology (Oxford); 2020 Jun; 59(6):1204-1206. PubMed ID: 32374851
[No Abstract] [Full Text] [Related]
5. [Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020].
Schulze-Koops H; Iking-Konert C; Leipe J; Hoyer BF; Holle J; Moosig F; Aries P; Burmester G; Fiehn C; Krause A; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wagner U; Krüger K; Specker C; ;
Z Rheumatol; 2020 Sep; 79(7):679-685. PubMed ID: 32757030
[TBL] [Abstract][Full Text] [Related]
6. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
[TBL] [Abstract][Full Text] [Related]
7. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
[TBL] [Abstract][Full Text] [Related]
8. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.
Schulze-Koops H; Krüger K; Hoyer BF; Leipe J; Iking-Konert C; Specker C;
Rheumatology (Oxford); 2021 May; 60(5):2128-2133. PubMed ID: 33502500
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and rheumatology: is shielding really necessary?
Amani L; Warraich R; Patel N; Tahir H
Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589537
[TBL] [Abstract][Full Text] [Related]
10. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.
Sarzi-Puttini P; Marotto D; Antivalle M; Salaffi F; Atzeni F; Maconi G; Monteleone G; Rizzardini G; Antinori S; Galli M; Ardizzone S
Autoimmun Rev; 2020 Jul; 19(7):102574. PubMed ID: 32376399
[TBL] [Abstract][Full Text] [Related]
11. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.
Saldarriaga Rivera LM; Fernández Ávila D; Bautista Molano W; Jaramillo Arroyave D; Bautista Ramírez AJ; Díaz Maldonado A; Hernán Izquierdo J; Jáuregui E; Latorre Muñoz MC; Restrepo JP; Segura Charry JS
Reumatol Clin (Engl Ed); 2020; 16(6):437-446. PubMed ID: 32800760
[TBL] [Abstract][Full Text] [Related]
12. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases.
Boyadzhieva VV; Stoilov NR; Stoilov RM
Rheumatol Int; 2020 Nov; 40(11):1753-1762. PubMed ID: 32930863
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L;
Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435
[TBL] [Abstract][Full Text] [Related]
15. Greetings from the editor.
Smolen JS
Ann Rheum Dis; 2020 Jun; 79(6):677-678. PubMed ID: 32434810
[No Abstract] [Full Text] [Related]
16. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Weinkove R; McQuilten ZK; Adler J; Agar MR; Blyth E; Cheng AC; Conyers R; Haeusler GM; Hardie C; Jackson C; Lane SW; Middlemiss T; Mollee P; Mulligan SP; Ritchie D; Ruka M; Solomon B; Szer J; Thursky KA; Wood EM; Worth LJ; Yong MK; Slavin MA; Teh BW
Med J Aust; 2020 Jun; 212(10):481-489. PubMed ID: 32401360
[TBL] [Abstract][Full Text] [Related]
17. How to manage rheumatic patients during the coronavirus pandemic.
Parisi S; Ditto MC; Finucci A; Fusaro E
Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
[No Abstract] [Full Text] [Related]
18. Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
Vakil-Gilani K; O'Rourke K
Clin Rheumatol; 2020 Jul; 39(7):2067-2068. PubMed ID: 32474884
[No Abstract] [Full Text] [Related]
19. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.
Ceribelli A; Motta F; De Santis M; Ansari AA; Ridgway WM; Gershwin ME; Selmi C
J Autoimmun; 2020 May; 109():102442. PubMed ID: 32253068
[TBL] [Abstract][Full Text] [Related]
20. How did COVID-19 pandemic changed the Portuguese rheumatology?
Vieira-Sousa E; Fonseca JE; Santos MJ
Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
